Anxiety
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1048
|
287
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2020 |
Anxiety Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
840
|
163
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2020 |
Progressive cGVHD
|
disease |
|
Disease or Syndrome
|
384
|
40
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2020 |
Multiple Sclerosis, Secondary Progressive
|
disease |
Immune System Diseases; Nervous System Diseases
|
Disease or Syndrome
|
20
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Negative affectivity
|
disease |
|
Mental or Behavioral Dysfunction
|
17
|
8
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Zika Virus Infection
|
disease |
Infections
|
Disease or Syndrome
|
192
|
1
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Leukoencephalopathy
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
189
|
17
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Cerebral atrophy
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
454
|
44
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Tremor, Limb
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
20
|
3
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Memory impairment
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
763
|
48
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Hyperlipoproteinemia Type IIa
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
201
|
661
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Psychiatric symptom
|
phenotype |
|
Sign or Symptom
|
95
|
12
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Fatigability
|
phenotype |
|
Sign or Symptom
|
29
|
4
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Brain atrophy
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
182
|
46
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Pleocytosis
|
disease |
Pathological Conditions, Signs and Symptoms; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
31
|
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Radiologically isolated syndrome
|
disease |
Immune System Diseases; Nervous System Diseases
|
Disease or Syndrome
|
8
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Autoimmune demyelinating disease
|
disease |
Immune System Diseases; Nervous System Diseases
|
Disease or Syndrome
|
6
|
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Human immunodeficiency virus (HIV) II infection category B1
|
disease |
|
Disease or Syndrome
|
985
|
56
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Multiple Sclerosis, Primary Progressive
|
disease |
Immune System Diseases; Nervous System Diseases
|
Disease or Syndrome
|
37
|
2
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Multiple Sclerosis, Relapsing-Remitting
|
disease |
Immune System Diseases; Nervous System Diseases
|
Disease or Syndrome
|
206
|
7
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Multiple sclerosis relapse
|
disease |
|
Disease or Syndrome
|
19
|
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Sjogren's Syndrome
|
disease |
Eye Diseases; Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases; Stomatognathic Diseases
|
Disease or Syndrome
|
481
|
47
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Dysphonia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Respiratory Tract Diseases; Nervous System Diseases; Otorhinolaryngologic Diseases
|
Mental or Behavioral Dysfunction
|
77
|
4
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Lower Urinary Tract Symptoms
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
77
|
30
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |